Important pharmacy news and late-breaking industry information updated daily.

In 2005, CDC published guidelines on tuberculosis (TB) prevention. As part of the prevention strategy, CDC recommended annual testing for health care workers at risk of exposure to TB while performing their jobs. Despite a lack of evidence on the screening’s effectiveness in reducing TB transmission to this population, the recommendation was adopted across the country. A new update to the guidelines suggests that while baseline screening should continue, serial screenings are not needed for health care workers who do not have latent TB.

The Trump administration on Wednesday said it was weighing plans to allow for the legal importation of prescription drugs from Canada, but pharmacists, patient groups, doctors, and some lawmakers in that country worry that the large-scale importation of pharmaceuticals could deplete the drug supply for its 37 million residents.

The Trump administration on Wednesday reported that it is taking steps to make it easier to import less expensive prescription drugs from other countries, particularly Canada. The proposal would permit pilot programs developed by states, pharmacies, or drug distributors that seek to safely import prescription medications from Canada.

In late June, science was made when Camille Schrier, PharmD candidate and APhA member, was crowned Miss Virginia 2019. Pharmacy Today was lucky to catch up with Schrier for an interview. Below is an edited version of the conversion. For the full article, please visit for the August 2019 issue of Pharmacy Today.

Results of two recently published studies suggest that for patients with mild asthma, clinicians may need to rethink the current recommended treatment algorithm. The Novel START trial showed that use of budesonide-formoterol (Symbicort Turbuhaler—AstraZeneca) as needed was superior to albuterol as needed to prevent asthma exacerbations in patients with mild asthma. The SIENA trial showed that many patients with mild, persistent asthma have a low sputum eosinophil level and do not derive additional benefit from treatments such as mometasone (Asmanex—Merck) or tiotropium (Spiriva—Boehringer Ingelheim).

In the second day of hearings about youth vaping and Juul Labs, a House subcommittee asserted Thursday that the company targeted children and teenagers.

FDA on Wednesday approved glucagon nasal powder (Baqsimi—Eli Lilly). This is the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection. The product is approved to treat severe hypoglycemia in patients with diabetes aged 4 years and older.

The Senate Finance Committee on Tuesday released a bipartisan drug-pricing proposal that would cap older adults' out-of-pocket costs and limit price increases in Medicare. However, the legislation faces opposition from the pharmaceutical industry and conservative groups. The proposal from Committee Chairman Charles E.

FDA announced Monday that it has approved nine applications for the generic versions of pregabalin (Lyrica—Pfizer) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients aged 17 years a

Cities, towns, and counties on Friday filed thousands of documents from corporations across the pharmaceutical supply chain as they laid out a detailed case of how diverse interests fed an opioid epidemic that persisted for nearly 2 decades.